Andrew S Boyer sold $1.1M of Amneal Pharmaceuticals (AMRX)

Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.

Value, as filed

$1.1M

125,000 sh × $8.89

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AB Andrew S Boyer Executive Vice President profile →

Andrew S Boyer (Executive Vice President) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $2.6M of AMRX (279,244 sh × $9.38, as filed), executed Aug 20 2025.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew S Boyer in AMRX

AMRXSALE Amneal Pharmaceuticals, Inc. $2.6M
279,244 sh × $9.38
Exec Aug 20 2025
Filed Aug 22 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $303K
33,436 sh × $9.05
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET